Loading clinical trials...
Loading clinical trials...
Multicentre, Controlled, Randomised, Investigator-Blinded, Comparative Study of Oral Mesalazine 4g Once Daily Versus Mesalazine 4g in Two Divided Doses in Patients With Active Ulcerative Colitis.
Conditions
Interventions
Mesalazine slow-release granules
Mesalazine liquid enema
Locations
66
Belgium
O.L.Vrouwziekenhuis Campus Aalst
Aalst, Belgium
C.H.U. Saint-Pierre
Brussels, Belgium
Saint Luc University Hospital
Brussels, Belgium
Universitair Ziekenhuis Brussel
Brussels, Belgium
U.Z. Antwerpen
Edegem, Belgium
University Hospital Gasthuisberg
Leuven, Belgium
Start Date
November 1, 2008
Primary Completion Date
June 1, 2010
Completion Date
June 1, 2010
Last Updated
March 4, 2015
NCT07271069
NCT06975722
NCT07185009
NCT07184996
NCT07245394
NCT07089420
Lead Sponsor
Ferring Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions